Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.86%37.66M | 6.49%35.45M | 18.13%142.38M | -4.71%19.32M | 43.98%46.55M | 36.15%43.22M | -10.10%33.29M | 1.91%120.54M | -12.10%20.28M | -12.91%32.33M |
| Cost of revenue | -20.17%27.68M | 1.33%25.11M | 15.32%108.85M | -0.39%13.26M | 39.82%36.13M | 32.26%34.68M | -19.34%24.78M | 4.06%94.39M | -12.23%13.31M | -11.35%25.84M |
| Gross profit | 16.80%9.98M | 21.54%10.34M | 28.24%33.53M | -12.95%6.06M | 60.53%10.42M | 54.61%8.54M | 34.96%8.51M | -5.19%26.15M | -11.84%6.97M | -18.61%6.49M |
| Operating expense | 11.15%9.93M | 14.04%9.33M | 6.08%37.07M | -23.49%11.9M | 19.66%9.67M | 15.94%8.93M | -1.04%8.18M | -5.13%34.94M | 2.86%15.55M | 8.31%8.08M |
| Selling and administrative expenses | 11.15%9.93M | 14.04%9.33M | 6.08%37.07M | -23.49%11.9M | 19.66%9.67M | 15.94%8.93M | -1.04%8.18M | 4.33%34.94M | 32.01%15.55M | 8.31%8.08M |
| -Selling and marketing expense | 15.75%485K | 12.46%370K | 86.51%1.82M | 255.37%188K | 112.47%886K | 15.43%419K | 1.23%329K | -6.61%977.78K | -12,073.04%-121K | 1.96%417K |
| -General and administrative expense | 10.92%9.44M | 14.10%8.96M | 3.77%35.24M | -25.28%11.71M | 14.61%8.78M | 15.96%8.51M | -1.13%7.85M | 4.69%33.96M | 33.03%15.67M | 8.68%7.66M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.46%5.36M | ---- | ---- |
| Operating profit | 112.28%48K | 209.17%1.01M | 59.83%-3.53M | 32.05%-5.83M | 147.42%753K | 82.06%-391K | 116.67%327K | 4.94%-8.79M | -18.95%-8.58M | -407.16%-1.59M |
| Net non-operating interest income (expenses) | 6.79%-1.95M | 6.77%-1.91M | -9.39%-8.4M | 1.51%-2.08M | -12.60%-1.98M | -22.08%-2.09M | -18.81%-2.05M | -21.63%-7.68M | -7.88%-2.12M | -12.95%-1.76M |
| Non-operating interest income | ---- | ---- | 693.26%259.97K | ---- | ---- | ---- | ---- | --32.77K | ---- | ---- |
| Non-operating interest expense | -6.79%1.95M | -6.77%1.91M | 11.88%8.61M | -1.51%2.08M | 12.60%1.98M | 22.08%2.09M | 18.81%2.05M | 21.83%7.69M | 7.88%2.12M | 12.95%1.76M |
| Total other finance cost | ---- | ---- | 176.05%54.18K | ---- | ---- | ---- | ---- | --19.63K | ---- | ---- |
| Net investment income | 381.79%419.25K | 87.02K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 125.88%1.12M | -4.33M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---497.01K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Less:Other special charges | ---- | ---- | -889.32%-2.78M | ---- | ---- | ---- | ---- | ---281.45K | ---- | ---- |
| Less:Write off | ---- | ---- | -53.13%2.16M | ---- | ---- | ---- | ---- | --4.61M | ---- | ---- |
| Other non-operating income (expenses) | -42.64%744K | 51.54%4.12M | -74.20%56.26K | -74.20%257K | -386.71%-453K | 127.54%1.3M | 1,153.46%2.72M | -77.73%218.12K | 130.86%996K | -5.95%158K |
| Income before tax | 2.36%-1.16M | 223.84%3.22M | 49.57%-10.34M | 21.06%-7.66M | 47.24%-1.68M | 64.36%-1.18M | 128.62%994K | -40.54%-20.5M | -10.95%-9.7M | -264.80%-3.19M |
| Income tax | 16.61%323K | 195.04%714K | 11.37%998.83K | -2,112.50%-161K | 137.04%512K | -20.17%277K | -44.87%242K | -20.34%896.84K | -98.32%8K | -24.21%216K |
| Net income | -1.23%-1.48M | 233.11%2.51M | 47.01%-11.34M | 22.79%-7.5M | 35.56%-2.2M | 60.18%-1.46M | 119.22%752K | -36.18%-21.39M | -5.31%-9.71M | -193.79%-3.41M |
| Net income continuous operations | -1.23%-1.48M | 233.11%2.51M | 47.01%-11.34M | 22.79%-7.5M | 35.56%-2.2M | 60.18%-1.46M | 119.22%752K | -36.18%-21.39M | -5.31%-9.71M | -193.79%-3.41M |
| Noncontrolling interests | 168.65%994K | 2,071.43%414K | 436.52%403.06K | 3.80%-253K | 40.77%656K | 216.35%370K | -290.91%-21K | -135.15%-119.77K | -1,160.78%-263K | 34.68%466K |
| Net income attributable to the company | -35.06%-2.47M | 170.50%2.09M | 44.82%-11.74M | 23.31%-7.25M | 26.38%-2.85M | 45.36%-1.83M | 119.70%773K | -32.54%-21.27M | -2.18%-9.45M | -157.24%-3.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -35.06%-2.47M | 170.50%2.09M | 44.82%-11.74M | 23.31%-7.25M | 26.38%-2.85M | 45.36%-1.83M | 119.70%773K | -32.54%-21.27M | -2.18%-9.45M | -157.24%-3.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -34.72%-0.0097 | 173.33%0.0082 | 44.83%-0.0459 | 23.51%-0.0283 | 26.32%-0.0112 | 45.04%-0.0072 | 119.61%0.003 | -30.82%-0.0832 | -2.78%-0.037 | -149.18%-0.0152 |
| Diluted earnings per share | -34.72%-0.0097 | 173.33%0.0082 | 44.83%-0.0459 | 23.51%-0.0283 | 26.32%-0.0112 | 45.04%-0.0072 | 119.61%0.003 | -30.82%-0.0832 | -2.78%-0.037 | -149.18%-0.0152 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.